Resolution
|
Total
votes for*
|
%
|
Total
votes against
|
%
|
Total votes cast |
Votes withheld**
|
|
1
|
Receive
and adopt the 2018 Annual Report
|
3,556,826,649
|
99.95
|
1,863,433
|
0.05
|
3,558,690,082
|
7,283,024
|
2
|
Approve
the Annual report on remuneration
|
3,157,857,593
|
88.77
|
399,443,579
|
11.23
|
3,557,301,172
|
8,672,905
|
3
|
Election
of Iain Mackay
|
3,509,580,387
|
98.56
|
51,394,236
|
1.44
|
3,560,974,623
|
4,999,291
|
4
|
Re-election
of Philip Hampton
|
3,523,220,874
|
98.94
|
37,814,132
|
1.06
|
3,561,035,006
|
4,939,054
|
5
|
Re-election
of Emma Walmsley
|
3,543,610,930
|
99.50
|
17,645,007
|
0.50
|
3,561,255,937
|
4,724,016
|
6
|
Re-election
of Vindi Banga
|
3,520,241,639
|
98.87
|
40,257,748
|
1.13
|
3,560,499,387
|
5,474,256
|
7
|
Re-election
of Dr Hal Barron
|
3,542,101,484
|
99.46
|
19,107,976
|
0.54
|
3,561,209,460
|
4,763,464
|
8
|
Re-election
of Dr Vivienne Cox
|
3,494,225,537
|
98.85
|
40,751,267
|
1.15
|
3,534,976,804
|
30,997,813
|
9
|
Re-election
of Lynn Elsenhans
|
3,543,230,972
|
99.50
|
17,848,986
|
0.50
|
3,561,079,958
|
4,893,685
|
10
|
Election
of Dr Laurie Glimcher
|
3,543,924,853
|
99.52
|
17,255,115
|
0.48
|
3,561,179,968
|
4,793,241
|
11
|
Re-election
of Dr Jesse Goodman
|
3,543,465,739
|
99.50
|
17,643,172
|
0.50
|
3,561,108,911
|
4,864,732
|
12
|
Re-election
of Judy Lewent
|
3,513,131,684
|
98.66
|
47,693,254
|
1.34
|
3,560,824,938
|
5,154,954
|
13
|
Re-election
of Urs Rohner
|
3,434,585,693
|
96.46
|
126,031,133
|
3.54
|
3,560,616,826
|
5,356,667
|
14
|
Re-appointment
the auditor
|
3,557,236,743
|
99.88
|
4,327,420
|
0.12
|
3,561,564,163
|
4,412,192
|
15
|
Remuneration
of auditor
|
3,554,992,184
|
99.83
|
6,020,952
|
0.17
|
3,561,013,136
|
4,948,179
|
16
|
Authority
for the company to make donations to political organisations and
incur political expenditure
|
3,471,514,277
|
98.00
|
70,681,915
|
2.00
|
3,542,196,192
|
23,791,786
|
17
|
Authority
to allot shares
|
3,444,525,603
|
96.77
|
114,953,481
|
3.23
|
3,559,479,084
|
6,482,169
|
18
|
Disapplication
of pre-emption rights - general power***
|
3,480,629,187
|
97.84
|
76,741,126
|
2.16
|
3,557,370,313
|
8,607,071
|
19
|
Disapplication
of pre-emption rights - in connection with an acquisition or
specified capital investment***
|
3,390,801,857
|
95.31
|
166,798,143
|
4.69
|
3,557,600,000
|
8,370,163
|
20
|
Authority
for the company to purchase its own shares***
|
3,509,141,893
|
98.57
|
50,794,321
|
1.43
|
3,559,936,214
|
6,028,543
|
21
|
Exemption
from statement of senior statutory auditor's name
|
3,524,087,916
|
99.51
|
17,395,554
|
0.49
|
3,541,483,470
|
24,488,266
|
22
|
Authority
for reduced notice of a general meeting other than an
AGM***
|
3,271,677,728
|
92.38
|
269,908,346
|
7.62
|
3,541,586,074
|
24,387,840
|
Resolution
|
Total
votes for*
|
%
|
Total
votes against
|
%
|
Total votes cast |
Votes withheld**
|
|
1
|
To
approve the transaction between GlaxoSmithKline plc,
GlaxoSmithKline Consumer Healthcare Holdings Limited and Pfizer,
Inc for the purposes of Chapter 11 of the Listing Rules of the
Financial Conduct Authority
|
3,496,633,023
|
99.85
|
5,302,329
|
0.15
|
3,501,935,352
|
24,272,073
|
|
|
|
|
|
|
|
|
*
|
Includes
discretionary votes. In line with the notification issued to
American Depositary Receipt (ADR) holders earlier this year, GSK
did not instruct its ADR Depositary to vote any unvoted ADRs in
respect of the resolutions for the 2019 AGM and GM
|
**
|
A vote
withheld is not a vote in law and is not counted in the calculation
of the proportion of votes "For" or "Against" a
resolution.
|
***
|
Indicates
Special Resolutions requiring a 75% majority.
|
|
GSK's
Nineteenth
AGM
(2019)
|
GSK's
Eighteenth
AGM
(2018)
|
Issued
share capital (excluding Treasury Shares)
|
4,987,806,108
|
4,959,302,644
|
Total
votes cast and votes withheld lodged as a % of GSK's issued share
capital (excluding Treasury Shares)
|
71.49%
|
78.76%
|
Total
shareholder population
|
108,698
|
112,326
|
Total
number of proxies lodged
|
6,635
|
6,931
|
% of
shareholders who lodged proxies
|
6.10%
|
6.17%
|
Number
of shareholders, corporate representatives and proxies who attended
the AGM
|
241
|
415
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: May
08, 2019
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|